Tower Research Capital (TRC)’s Healthcare Capital Corp. Class A common stock HCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,146
Closed -$21K 7120
2021
Q4
$21K Buy
2,146
+1,602
+294% +$15.9K ﹤0.01% 3647
2021
Q3
$5K Buy
+544
New +$5.34K ﹤0.01% 4937

Tower Research Capital (TRC)'s HCCC Position: Q1 2022 in Review

Tower Research Capital (TRC) sold out of Healthcare Capital Corp. Class A common stock (HCCC) in Q1 2022, closing a stake of 2,146 shares — an estimated $21K sold.

Tower Research Capital (TRC) first reported a position in HCCC in Q3 2021 and held it in 2 quarters. The position peaked at $21K in Q4 2021. 0 funds tracked by Wall St. Rank hold HCCC as of Q1 2022.

  • Tower Research Capital (TRC) reported no remaining Healthcare Capital Corp. Class A common stock position as of Q1 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,146 Healthcare Capital Corp. Class A common stock shares in Q1 2022, an estimated $21K.
  • Tower Research Capital (TRC) first reported a position in Healthcare Capital Corp. Class A common stock in Q3 2021 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Healthcare Capital Corp. Class A common stock position peaked at $21K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Healthcare Capital Corp. Class A common stock as of Q1 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.